Malignant Neoplasms: Clinical Trials

4 trials for Malignant Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Unknown 4

Follow Malignant Neoplasms: new trials by email Literature Review of Malignant Neoplasms trials Research Report on Malignant Neoplasms

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1,Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors
BPI-421286 - Malignant Neoplasms, Metastatic Cancer
Phase 1UnknownBetta Pharmaceuticals Co., Ltd.802021-08-242022-04-07
A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer
SCART radiation therapy - Malignant Neoplasms
Phase 1UnknownBaptist Health, Louisville122021-06-052021-05-11
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
CT-0508, Pembrolizumab - HER2-positive, Adenocarcinoma
Phase 1UnknownCarisma Therapeutics Inc482021-02-022024-12-18
A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors
IMMH-010 - Malignant Neoplasms
Phase 1UnknownTianjin Chasesun Pharmaceutical Co., LTD962020-05-142023-11-09

Narrower conditions

Neoplasms (4)  ·  Colorectal Neoplasms (2)  ·  Neoplasm Metastasis (2)  ·  Pancreatic Neoplasms (2)  ·  Adenocarcinoma (1)  ·  Bile Duct Neoplasms (1)  ·  Biliary Tract Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Ductal (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Carcinoma, Small Cell (1)  ·  Carcinoma, Squamous Cell (1)  ·  Carcinoma, Transitional Cell (1)

Broader conditions

Colonic Diseases (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Intestinal Diseases (2)  ·  Intestinal Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Neoplastic Processes (2)  ·  Pancreatic Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Rectal Diseases (2)

Interventions

pembrolizumab (1)

Sponsors

Baptist Health, Louisville (1)  ·  Betta Pharmaceuticals Co., Ltd. (1)  ·  Carisma Therapeutics Inc (1)  ·  Tianjin Chasesun Pharmaceutical Co., LTD (1)

Countries

China (3)  ·  United States (2)

Top investigators

Jeanett Wetzel (1)  ·  Yilong Wu (1)

Results publications

PMID 34234673, PMID 36441083, PMID 39726590, PMID 39920391